S100A9 and hepatocellular carcinoma: In summary, our study illustrated that preoperative TACE may increase the expression of S100A9 by creating a hypoxic tumor microenvironment, leading to the formation of metastases and resulting in a high rate of tumor recurrence in HCC patients.